Here’s what you should know.
1. The “Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee System” recently enrolled its first patient.
2. Researchers will conduct a prospective, single arm, multicenter, post-market study of U2 Knee System’s short and long term performance and implant survivorship.
3. David Cashen, MD, an orthopedic surgeon at Bradenton, Fla.-based Coastal Orthopedics, is leading the study.
4. Researchers plan on enrolling up to 200 patients and will follow the patients for seven years.
More articles on orthopedic devices:
Neurosurgeon wins $88.7k+ in retaliation case against NY hospital over concurrent surgeries: 5 things to know
Dr. Brian McKeon advises Boston Celtics’ Isaiah Thomas on hip injury: 5 key notes
Americans anxious about their health — who feels it most? 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
